INTRODUCTION
In the second half of the 19th century, all cases of nonvalvular heart disease were termed myocarditis (140) . Currently, myocarditis is defined as inflammatory infiltration of the muscular layer of the heart associated with myocyte injury, which does not resemble ischemic infarction (4) . This definition attempts to exclude a variety of conditions in which lymphoid cells may be observed in the heart without specifically causing myocardial injury. In active myocarditis, cardiac injury is a direct consequence of inflammatory cells entering the heart, and these mononuclear cells must be in intimate contact with areas of damage (4) . Adjacent portions of the same myofiber bundles may appear normal. This is in contrast to other conditions such as malignancy, ischemia, or trauma, in which lymphoid cells may be present in the myocardium either without causing myocyte damage or only to remove tissue destroyed by other mechanisms. Because so many conditions mimic myocarditis, estimates of this disease at autopsy, which range from 1 to 4% (123, 144) , are undoubtedly inaccurate.
Myocarditis can have both infectious and noninfectious etiologies. Hypersensitivity reactions, along with chemical and drug toxicities, account for the preponderance of these etiologies, especially when alcohol and adriamycin cardiomyopathy are included. Among cardiovascular diseases initiated by known infectious agents, Chagas' disease caused by Trypanosoma cruzi clearly ranks worldwide as the major and most serious form (Public Health Laboratory Service Report, Memorandum, Br. Med. J. 4:575-577, 1967 ). This disease rarely occurs outside of South America, however, except through emigration of infected individuals prior to onset of cardiac symptoms. Rheumatic heart disease (27) and Lyme disease (134) are both examples of inflammatory heart disease initiated by microbial infection. While the incidence of the former illness is rapidly decreasing in much of the industrialized world, that of the latter, a recently identified syndrome initiated through spirochete infection, is expanding.
Today, most cases of myocarditis in the United States and Europe, when an etiological agent can be determined, result from a variety of viral infections (147) . Many viruses have been implicated in myocarditis (147) , but the principal agents belong to the picornavirus family (36, 39, 124, 136, 139, 147 This virus group (poliovirus, coxsackievirus, echovirus, and rhinovirus) was discovered as a by-product of the intensive study of poliovirus infection during the 1940s. Successful isolation of specific viruses in primary human myocarditis has been principally confined to coxsackieviruses (39, 138, 139) and other picornaviruses (66, 100) , and it is now generally accepted that coxsackievirus B (CVB), types 1 to 5, is the predominant cause of human viral myocarditis (77) . In this review, we will examine the role of coxsackieviruses in human myocarditis and present clinical and experimental data regarding the pathogenicity of these cardiotropic microorganisms. Furthermore, we will present evidence in support of the hypothesis that this cardiotropism has serious implications with respect to the development of chronic inflammatory heart disease and cardiac failure (cardiomyopathy). THE 
CLINICAL DISEASE
The principal clinical symptom of myocarditis is chest pain (131) . This complaint may be supported by electrocardiographic changes consisting of sinus tachycardia, ST-T segment abnormalities, and ventricular conduction disturbances (147) . Critical to the diagnostic consideration of myocarditis in any patient is the absence of preexisting cardiac disease (99) . The clinical presentation is somewhat dependent on the age of the patient. Infants may show tachycardia, inactivity, and pyrexia during the acute phase of the disease. There may be nonspecific electrocardiographic findings and evidence for multiorgan involvement (147) . In adults, initial chest pain may be accompanied or followed by symptoms of pericarditis (147) . Acute sequelae, although rare, include coronary artery occlusion, rapidly progressive heart failure, and sudden death (147) . Other signs of the acute disease include tachycardia, murmurs, arrhythmias, rales, and cardiomegaly. Electrocardiogram changes in adults include ST-T wave abnormalities, conduction disturbances, and Q-wave abnormalities (1, 147) . Un- fortunately, such dramatic clinical findings are not always present. To emphasize this point, even when chronic myocarditis is identified histologically, in many cases an acute phase of the disease cannot be identified historically by the patient or physician. It is likely that the majority of individuals with acute myocarditis experience no more than a mild flulike illness with nonspecific symptoms and vague clinical signs of heart disease (107) . The (95) . In humans, persistent inflammatory cell infiltrates in the heart have been observed histologically in patients recovering from well-documented acute viral myocarditis (11) . Conversely, lymphocytic infiltration of the heart was identified in 87% of 108 patients dying with cardiomyopathy by Billingham and Tazaalar (11) and in 63% of 35 patients evaluated by EMB for unexplained heart failure by Zee-Cheng et al. (150) . Objective histologic evidence for myocyte necrosis in these studies is atypical. The exact reason for this phenomenon is unknown but may be related to the limited sample size of the biopsies or may be indicative of low sensitivity of morphologic assessment alone in this diagnosis. Regarding the latter point, other diagnostic modalities have been evaluated recently in the diagnosis of myocarditis. These include radioisotopic scans of the heart, using gallium-67 citrate (108) and indium-111-labeled monoclonal antibodies to myosin (149) . Indeed, these noninvasive techniques may prove to be an important part of the total assessment of myocarditis in conjunction with other clinical and laboratory diagnostic methods.
Three commonly used laboratory methods are available to implicate virus as a cause of myocarditis in patients presenting with symptoms and signs suggestive of this disease (76, 147) . First, and most common, antibody response to a specific virus can be documented by using the patient's serum. This method requires paired sera obtained during acute and convalescent phases of the infection to detect a minimum of a fourfold rise in antiviral antibody titer (16 ACUTE AND CHRONIC MYOCARDITIS: RELATIONSHIP TO DILATED CARDIOMYOPATHY Subacute and chronic inflammatory heart disease can be seen in patients months to years after acute viral myocarditis. The chronic disease is manifested pathologically by the presence of interstitial cardiac fibrosis, with or without inflammation, myocardial hypertrophy, and chamber dilation as the heart fails (1). The clinical manifestations are those of progressive congestive heart failure and have been termed cardiomyopathy. The incidence of dilated cardiomyopathy in the United States is estimated at 10 per 100,000 population per year (147) , but no good estimates are available to indicate the number of patients whose disease was caused by viral agents. Congestive heart failure may have many causes and represents the end stage of several distinct and unrelated diseases. Thus, only a fraction of myocarditis patients ultimately progress to cardiomyopathy, and myocarditis-associated cardiomyopathy represents only a fraction of the total population developing congestive heart failure.
As emphasized earlier, one of the major problems with identifying the evolution of myocarditis to dilated cardiomyopathy is that, in most patients, the symptoms of the acute disease may be nonspecific and mild, obviating the possibility of early diagnostic studies. Furthermore, careful examination of the heart and detailed historical evaluation fail to implicate a viral etiology in the majority of patients suffering from or dying with cardiomyopathy. For this reason, most of our knowledge about the natural history of viral myocarditis has been derived from anecdotal case reports and a relatively small number of published series of cases involving highly selected patients (106) .
Kline and Saphir documented progressive myocardial failure in 29 patients months to years after acute myocarditis (74) . Several studies have documented persistent and progressive symptoms, along with chest X-ray and electrocardiogram abnormalities, following acute viral myocarditis (predominately coxsackieviruses) (8, 50, 120, 131, 132) . Miklozek et al. followed 16 patients diagnosed as having viral myocarditis by using serial cardiac function tests. They found that 75% of these individuals had one or more abnormal tests during the course of their study (99) . Abelmann examined cardiac function in patients with diagnosed myocarditis (1). Patients were accepted for serial study only after other possible causes of cardiac decompensation were excluded. As part of the evaluation, a Holter monitor was used to monitor heart function continuously. Intraventricular conduction defects, atrioventricular block, frequent premature ventricular or atrial beats, and supraventricular tachycardia were documented. Viral studies included culture and a search for antibodies directed against cytomegalovirus and Epstein-Barr virus. Some 44% of patients had cardiac symptoms, and 63% had an abnormal physical exam over the course of follow-up. The overall conclusion was that persistent cardiac dysfunction is not unusual after recovery from the acute viral illness. Ayuthya et al. studied 50 consecutive patients with dilated cardiomyopathy and found significantly higher incidences and levels of neutralizing antibodies to coxsackieviruses in these patients than in controls (5) . Recent work by Bowles et al. (12) and Kandolf et al. (67) has shown CVB-specific nucleic acid sequences in the heart tissue of patients with active or healing myocarditis as well as in a smaller number of patients with dilated cardiomyopathy. Unfortunately, these studies primarily serve to demonstrate the possibility that viral infections lead to cardiomyopathy rather than defining the susceptibility factors (such as specific virus types or a particular genetic predisposition of the host) which determine who will develop cardiomyopathy.
PICORNAVIRUS REPLICATION CYCLE Morphologic assessment of tissue obtained at autopsy or by EMB reveals some common morphologic changes in myocarditis and cardiomyopathy (91, 107) . From these studies, and from available data on experimental viral myocarditis, the following disease sequence can be deduced. Since picornaviruses constitute the predominant etiological agents in human viral myocarditis (135, 145) , the sections that follow will deal with these viruses.
Picornaviruses are small, nonenveloped viruses containing a single-stranded ribonucleic acid (RNA) of positive sense. The genome comprises approximately 30% of the molecular mass of the virus and is enclosed within an icosahedral protein capsid. The capsid consists of 60 protomers made up of equal numbers of four proteins designated VP1 through VP4. Antigenic sites for virus neutralization involve portions of each of these proteins. The surface of the protein capsid is irregular, with depressions resembling "canyons" which may hold the receptor sites required for binding to cell surface molecules. Furthermore, the rim of the canyon may be responsible for interactions with antibodies (81) . Virus usually enters the host by oralfecal transmission and establishes localized centers of virus replication. Nonspecific host defenses influence this process (69) . Enteric viruses must be resistant to low pH, proteolytic enzymes, and the detergent action of bile salts to establish an infection. Following multiplication and release of virions into the circulation, viremia develops, seeding the infectious agents in selected tissues (69) .
Host specificity and tissue tropism have long been hallmarks of viral infections. Polioviruses, rhinoviruses, coxsackieviruses, and encephalomyocarditis (EMC) virus are typically human pathogens, while cardioviruses and apthoviruses infect mice and cloven-footed animals, respectively (115) . In addition to a specific host range, viruses have an affinity for particular tissues (115) . Well-known examples include the growth of poliovirus in the anterior horn cells of the spinal cord, coxsackievirus tropism for skeletal and cardiac muscle, and the replication of rhinovirus in the nasopharynx. Preliminary evidence in our laboratory indicates that endothelial cells derived from different tissues show distinct susceptibilities to CVB type 3 (CVB3) infections (Huber, unpublished observations). If true, endothelial cells may form the initial "gateway" to infection of an organ. Several factors are involved in determining tropism. Probably the most important of these is the presence of specific viral receptors on the host cell (18, 130) . These receptors are not well characterized, but probably are glycoproteins having molecular weights ranging from 5 x 104 to 9 x 104.
Picornaviruses have high mutation rates, with variants differing in pathogenicity, infection, and replication characteristics such as interferon induction and plaque size, antigenicity (97), and receptor recognition (19, 54) . Different variants may utilize distinct cellular receptors on the same cell or may distinguish between cell types, thus resulting in specific organ tropism. The number and location of virus receptors may differ between cell types and may vary depending on cell differentiation. Thus, tissues highly susceptible to picornavirus infection in neonatal or fetal periods may lose receptors in later life (115) . Following virus attachment, the next critical step in virus infection involves internalization of the virion through a process termed viroplexy. Attachment alone is insufficient to explain virus entry. Schultz and Crowell described a nonfusing myogenic cell line which expressed receptors for group A coxsackievirus but which was incapable of internalizing bound virus (128) . Other fusable myogenic cell lines were permissive and allowed virus replication. These observations suggest that characteristics of membrane fluidity and cytoskeletal elements may affect internalization of the virus. Rearrangements of the virus capsid occur soon after adsorption and result in loss of VP4, increased sensitivity to proteases and detergents, and loss of infectivity (22) .
The mechanism of entry into the cell varies among picornaviruses. Poliovirus is internalized by receptor-mediated endocytosis, while internalization of rhinovirus and EMC virus proceeds by other endocytic pathways (87, 151) . Receptor-mediated endocytosis involves the clustering of virus-receptor complexes in clathrin-coated pits which invaginate to form coated vesicles. Vesicles uncoat and fuse with intracellular vesicles to form endosomes. The endosomes containing virus particles may then fuse with lysosomes or the Golgi apparatus or directly release virus into the cytoplasm (151) . The uncoating of poliovirus and rhinovirus appears to require low pH, suggesting degradation of the capsid within lysosomes or endosomes (87, 151) while uncoating of EMC is not dependent on low pH (86 (118) .
Once virus is taken up by the cell into the cytoplasm, the genome acts as a messenger RNA for synthesis of virus proteins. One of the more interesting aspects of virus infections is the ability of the virus to interfere with and inhibit host protein synthesis, converting the cell into a viral "factory." The mechanism by which this event is accomplished is not completely understood but seems to function through gradual dissociation of the polysome complexes normally observed in the host cell cytoplasm, with ultimate reaggregation into considerably larger (350S) and more homogeneous polysomes which make virus polypeptides exclusively (6) . Since cellular messenger RNA remains in the cytoplasm and appears unaltered, virus-mediated inhibition of host protein synthesis probably occurs at the level of translational initiation. The precise mechanisms involved in this process are now being elucidated and apparently differ depending on the virus and the type of cell infected (64) . In the case of poliovirus-infected HeLa cells, cap-binding protein complex is inactivated, thus preventing translation of capped host messenger RNA while allowing translation of uncapped viral RNA (31) . Inhibition of protein synthesis occurs later in infection and gradually declines. Concurrent synthesis of cellular and viral proteins is seen throughout infection, but the viral portion of total synthesis increases (63) . These data suggest that EMC RNA simply competes for the factors necessary for translation. However, EMC infection of L cells results in a rapid shutoff of host translation which may proceed by yet another mechanism (64) . Other theories attribute protein synthesis inhibition to the toxic effects of coat protein, inactivation of factors for initiation, and accumulation of double-stranded RNA (115) .
RNA synthesis is also inhibited during picornavirus infection. Studies of cell-free transcription in extracts of poliovirus-infected HeLa cells indicate that a factor required for transcription by polymerase II is deficient in infected cells (17) . A viral protein may be responsible for this defect since treatment of cells with puromycin prevents inhibition of RNA synthesis (7) .
Picornaviruses require a host cell factor for synthesis of viral RNA (115) . Cells lacking the appropriate factor fail to produce functional progeny virions and infection is aborted even through viral receptor is expressed. Such infections still result in significant alterations in the host cell. Shutoff of deoxyribonucleic acid synthesis is probably secondary to alterations in RNA and protein syntheses. Cytopathic effects of picornavirus infection include increased plasma membrane permeability, presumably mediated through alterations in membrane composition. Intracellular components leak from the cytoplasm and the cell shrivels. Disintegration of the cell is probably due to the combined effects of inhibition of macromolecular synthesis and accumulation of virus and structural proteins (115) . In the experimental animal heart, myocytolysis is attended morphologically by coagulative cytoplasmic contraction and granularity, nuclear pyknosis, and cell fragmentation (54 (48) found that types 1 and 5 CVB produced myocarditis in suckling mice, but types 2, 3, and 4 were minimally myocarditic in this age group. On the other hand, all five types produced myocarditis in adult animals. Type 3 virus (both the Nancy strain and a second isolate) produces extensive cardiac lesions in weanling and adult animals. Variants of CVB3 have been produced which replicate in the heart but are not myocarditic (37, 38, 110) . In humans, variant CVB4 with different tissue tropisms can be isolated from the same person and are antigenically distinguishable from each other with monoclonal, but not polyclonal, antisera (113) .
The myocardial lesions observed in mouse hearts following CVB3 infection closely resemble those of the acute disease in humans (44, 47, 48, 51, 52, 72, 92, 109, 114, 118a) . Scattered necrotic foci are found throughout the ventricles and, to a lesser extent, in the atria. The pericardium and endocardium are rarely involved. A primary lesion consists of necrotic muscle fibers with pycnotic or absent nuclei, surrounded by mononuclear cells. Adjacent areas of the myocardium appear intact. Lesions may also occur around blood vessels and often involve periarteritis. Later, fibers are replaced with connective tissue or calcification or both, and the number of mononuclear cells diminishes (47, 51) . In strains of mice which are susceptible only to acute myocarditis (B strains [51] , BALB/c [60] , and CD-1 [145] ), the process described above resolves in 1 to 2 weeks. In strains susceptible to chronic disease (Swiss mice [145] and A strains [51, 118a] (78) .
A variety of mechanisms may be involved in myocyte injury after CVB3 infection. As indicated above, virus infection alone can induce significant cardiocyte alterations, and this form of injury may be substantially increased under certain conditions that enhance virus replication. Administration of cortisone to CVB3-infected mice completely blocks the inflammatory response in the heart, yet extensive fiber necrosis still occurs (146) . Heart viral titers from cortisone-treated animals were found to be 4 to 5 logs higher than titers from hearts of animals infected in the absence of cortisone, despite equivalent amounts of circulating virusneutralizing antibody in the two groups. This finding suggests that cardiac damage results solely from the cytolytic properties of the virus. The same pattern is seen in mice treated with anti-asialo GM1 to decrease natural killer cell activity (41) . This treatment also increases heart viral concentration 2 to 4 logs, and necrosis is extensive despite decreased inflammation. Other researchers have reported similar findings in animals that are immunosuppressed by dietary deprivation, exercise, and hypothermia (41, 117) . All of these conditions, however, are characterized by uncontrolled viral replication.
Under more normal conditions, it seems unlikely that the bulk of cardiac injury induced by CVB3 infection results from host responses to infection. CVB3-infected BALB/c mice depleted of T lymphocytes have heart virus titers equivalent to those of nonimmunocompromised infected controls, yet develop minimal myocarditis (57, 148) . Severe pathologic changes in the heart are rarely seen before day 5 postinfection, when lymphocytic infiltration begins and the viral titer is dropping rapidly (43, 62, 78, 147) . Inflammation and damage may continue for days or weeks after virus can no longer be detected. Also, light and electron microscopic studies have revealed that necrotic cardiocytes are surrounded by infiltrates comprised primarily of macrophages, T cells, and relatively few B cells (42) . Whether lymphocytic effector cells directly mediate tissue injury or only produce lymphokines activating other inflammatory cells which actually lyse cardiocytes is not known. However, some circumstantial evidence favors the hypothesis that macrophages participate in lesion formation since activated rat macrophages have receptors for L-mannosyl or L-fucosyl residues (129, 133) and murine heart tissues infected with a myocarditic variant of CVB3 express L-fucosyl residues as detected by lectin binding (82) .
HOST MECHANISMS LEADING TO VIRUS CLEARANCE
The natural result of infection is the induction of various cellular and humoral immune responses to virus antigens designed to eliminate the infectious agent before serious harm occurs. The interactions between the virus and myocardium, and between the host defense mechanisms and virus, are best illustrated in defined murine models of coxsackievirus-induced myocarditis. Coxsackieviruses can be found in the heart within 3 h of intraperitoneal inoculation, and viral replication in heart and other target organs is well established within 24 h (62, 85). Viral concentrations peak 3 to 4 days postinfection, after which time host immune mechanisms become activated and the virus is rapidly eliminated. Inflammatory cell infiltrates consisting of macrophages and lymphocytes first appear around day 5 (148) .
In vivo, alterations in cardiocytes can be detected by electron microscopy shortly after infection. Changes in nuclei include coarsened chromatin, enlarged nucleoli, and an increased number of nuclear pores (114) . By day 3 of infection, viral titers are at their highest level, but inflammatory cells are not yet present. Myofibers show disruption of myofilaments and mitochondria, as well as further degenerative changes in nuclei. Virus clearance is, in part, accomplished by neutralizing antibody directed to attachment epitopes on the virus that interfere with the interaction between the virion and the cell surface receptor. Rising titers of virus-specific IgM antibodies correlate with decreasing viral titers, since they appear 2 days after infection and peak at day 4. Virus-specific IgG is observed initially on day 6 and peaks at day 14 (62, 78). Complete protection from CVB3 infection and myocarditis can be achieved by administration of virus-neutralizing antibody to mice either shortly before or after virus inoculation (116) . Production of early-arising IgM antibodies is apparently not dependent on T cells, as this process is unaffected in T-cell-depleted mice during the first week (15, 148) . Similarly, coxsackieviral infection is readily cleared in nude mice (49) . However, antibody response at later time points is depressed in the presence of antithymocyte serum (146) , suggesting that T-helper cells are absolutely required for IgG responses and, therefore, contribute to long-term humoral immunity.
Virus-neutralizing antibodies are not the only factors acting in defense against coxsackieviral infection. Macrophages comprise the greatest percentage of the mononuclear infiltrate in the heart 5 to 10 days postinfection (42, 146, 148) , and they appear to work in conjunction with circulating antibodies to limit the spread of virus. When macrophages are prevented from entering the heart by cortisone treatment, CVB3-induced cardiac damage is severe and organ virus titers remain elevated despite normal levels of circulating antiviral antibody (146) . Administration of either immune serum or adult peritoneal exudate cells protects suckling mice from infection, showing that either host factor can influence virus replication. However, when suboptimal concentrations of peritoneal cells and antibody are simultaneously administered, protection is greatly enhanced (46, 47) . Similar evidence implicates interferon and natural killer (NK) cells in controlling picornavirus infections. NK cell activity was observed to be at a maximum 3 days after infection, correlating with peak virus titers (41) . Mice de- pleted of NK cells with anti-asialo GM1 antiserum exhibited increased virus titers in the heart and more severe myocarditis; thus, it appears that NK cells function to limit virus replication, which in turn decreases the severity of myocarditis even though NK cell activity does not correlate with the presence or absence of myocarditis (41) . There is also evidence that large, granular, activated splenic lymphocytes taken from CVB3-infected mice 3 days postinfection are capable of limiting CVB3 replication both in vitro and in vivo by killing virus-infected cells (43) . Interferon stimulates NK cells, activates macrophages, and prevents infection of healthy cells (41, 68) . As inbred mouse strains differ in their capacities for both interferon production and NK cell activity, these factors could contribute to the observed differences in response to coxsackieviral infection among different strains (37, 51 (80, 101, 138 (59) . One, designated virus-specific CTL, closely resembles the response described by the above investigators for exogenously produced virus peptides. Exposure of cardiocytes to either infectious or ultravioletirradiated, noninfectious CVB3 results in virus epitope expression capable of stimulating exclusively CD4 T cells (29) . Furthermore, as expected for this subset of effector cells, activity is class II MHC antigen restricted. Virusspecific VCTL distinguish between targets infected with CVB3 and other viruses such as EMC virus, demonstrating the antigen specificity of the response. No CD8 CTL reacting to coxsackievirus-infected cardiocytes have yet been described. One explanation is that the second pathway of antigen processing through Golgi-associated endosomes does not occur in cardiocytes, or possibly in any picornavirus-infected cell. Certainly, the CD8 virus-specific CTL described earlier were noted in influenza virus infections. Since this enveloped virus normally buds from the infected cell, and therefore requires insertion of virus glycoproteins into the plasma membrane, these virus molecules may be more likely to pass through the Golgi than picornavirus proteins which are not glycosylated and are required in the cytoplasm for virion assembly. Differences in cell compartmentalization of virus protein synthesis and utilization may favor one form of antigen processing over another and, therefore, be responsible for different types of virus-specific cellular immunity.
A second CTL that recognizes infected target cells has been described recently (55a). This CTL, unlike the virusspecific CTL, reacts to glycoproteins induced soon after infection but apparently not encoded in the virus genome. Gauntt and his colleagues first described an 80-kilodalton antigen on coxsackievirus-infected cells but not on uninfected cells (110, 111) . The new antigen, which reacts with the lectin Ulex europeaus agglutinin I, must contain carbohydrate elements. Since picornavirus proteins are not usually glycosylated, these investigators concluded that the new antigen must be of cellular origin and therefore represents a neoantigen (82) . Subsequently, a CTL was isolated which reacts to new cellular antigens induced on cardiocytes when cellular metabolism, including RNA and protein syntheses, is inhibited (55a). This CTL (designated metabolic CTL) was first identified when cardiocytes were treated with actinomycin D. Antigenic alterations in the cell membrane correlated identically with decreases in both uridine and leucine incorporation. Not surprisingly, identical antigenic changes were subsequently demonstrated on cardiocytes infected with either the myocarditic CVB3 variant or EMC virus, which both effectively inhibit cellular metabolism. A second and nonpathogenic CVB3 variant does not detectably alter protein synthesis in infected cells and fails to induce antigenic alterations recognizable by the metabolic CTL (55a). The nature of the antigen induced after metabolic alteration is not known but possibly represents a stress-related protein. important point, however, is that the same antigen arises after a variety of drug and virus treatments as long as cellular metabolism is altered. When multiple exposures to such agents are possible, the metabolic CTL may become increasingly important in both eliminating infected cells prior to completion of progeny virion replication and producing cardiac myocytolysis.
AUTOIMMUNITY IN MYOCARDITIS
A current controversy is centered on determining the major cause of cardiac injury in myocarditis patients. In some patients, cardiac lesions must result primarily from immunological mechanisms since immunosuppressive therapy proves markedly beneficial to these individuals (32, 94) . However, since many other patients either fail to improve or deteriorate during treatment (53), other mechanisms, including direct virus-mediated injury, may contribute to tissue injury. Myocytolysis resulting from replication and clearance of the infectious agent by either the virus itself or virus-specific immunity should be active only during periods of continued virus presence. Chronic myocarditis in both humans and mice persists for extended periods, after infectious virus can no longer be detected in the heart and when in situ hybridization procedures cannot demonstrate virus genomic material (12, 42) .
The question arises as to whether the initiating virus infection induces autoimmunity in the host to self-antigens. Several specific immunologic abnormalities have been identified in human myocarditis. Heart-reactive autoantibodies arise in 80 to 100% of myocarditis patients with a proven or suspected viral etiology. These antibodies are directed against a sizable array of distinct self-antigens including collagen, laminin, and fibronectin of the extracellular matrix (89), myosin (103, 104), actin (89), Ca2+ channel proteins (127a), and adenosine diphosphate-adenosine triphosphate carrier molecules usually associated with mitochondrial membranes (127) . Other autoantibodies exist which react to as yet unidentified cell surface molecules. Since at least some of these humoral effectors occur in apparently normal individuals and in individuals with ischemic heart injury, their role in causing cardiac damage in myocarditis is unclear.
Perhaps some of the most convincing evidence for a humoral immunopathogenic mechanism in clinical myocarditis comes from work done on antibodies directed to either calcium channel proteins (127a) or myolemmal antigens (88) . In the former studies, antibodies to the calcium channel or sarcolemmal proteins rapidly induced arrhythmias and physiological alterations. These antisarcolemmal antibodies lyse cultured myocytes in complement and antibody-dependent cell-mediated cytotoxicity assays and may therefore contribute to myocardial necrosis and myofiber dropout. Antisarcolemmal antibody titers correlate with disease severity, increasing during acute phases and waning as myocarditis resolves. Evidence for cellular autoimmunity in clinical disease is more difficult to obtain. Abnormal helper and suppressor T-lymphocyte numbers are observed during myocarditis (3, 26, 34, 122) , and T lymphocytes derived from biopsy specimens show significant reactivity to cardiac antigens in culture (75, 88, 89) .
While evidence of autoimmunity in human myocarditis remains only circumstantial, proof of such responses in the murine models is well accepted. Studies by Rose, Beisel, Wolfgram, Herskowitz, and their co-workers show that susceptibility to CVB3-induced myocarditis is under multigenic control (51, 118a) . These genes reside both within and outside of the MHC or H-2 region in the mouse and involve the loci controlling T-cell receptor and immunoglobulin responses. Autoantibodies to the heart arise in most strains of mice infected with coxsackievirus and are presumably pathogenic in many. DBA/2 mice inoculated with CVB3 develop a strong antiheart IgG response, and these antibodies can be detected in infected hearts by immunofluorescence (60) . Myocardial injury can be completely prevented in this strain by either complement depletion (60) or depletion of L3T4+ (T-helper) cells by monoclonal antibody (78) .
Several investigators (2, 103, 105, 118a) have also found that autoimmune heart antibodies are generated in strains of mice susceptible to chronic myocarditis. The autoantibody correlating most closely with tissue injury is directed against cardiac myosin (2, 103) . No cross-reactivity of this antibody with specific CVB3 antigens has been observed (104) . Immunization of susceptible mice with purified cardiac myosin elicits myocardial pathology within 14 to 21 days. IgG antibodies are present in the heart, and the relative amount of immunoglobin directly correlates to the severity of pathologic changes (118a). Furthermore, various strains of mice differ dramatically in their humoral response to the cardiac myosin isoform and only high responder strains develop myocarditis, further proving that autoimmunity to myosin is important in disease pathogenesis (103, 105) . It is unclear why myosin should elicit the bulk of an autoimmune response, and this may not be true for all animal strains exhibiting humoral autoimmunity. Possibly, viral injury of some cardiocytes results in increased myosin availability to the immune system similar to the hypothesized mechanisms of myelin basic protein autosensitization in experimental allergic encephalitis (55, 117a) .
Cellular autoimmunity also occurs during CVB3 myocarditis. CTL lysing infected and uninfected cardiocytes are detected in peripheral lymphoid tissue within 5 days of virus inoculation, and this activity peaks between weeks 1 and 2, when pathology is maximum. Lymphocytes positively selected for reactivity to uninfected myocytes demonstrate the existence of autoimmune CTL (59) . These effector cells recognize normally expressed antigens on uninfected cardiocytes. Autoimmune CTL belong to the CD8 phenotype, and depletion of this T-cell subset in vivo with monoclonal antibodies abrogates cardiac inflammation in infected mice (29) . Furthermore, autoimmune CTL effectively transfer myocarditis when adoptively injected into uninfected syngeneic animals, confirming both their autoimmune nature and their pathogenic potential (61) .
One of the interesting observations in the murine model is 153:372, 1986) . Whether this form of autoimmunity plays a major role in pathogenesis is not known, but it certainly will be investigated in the future. A second mechanism has been suggested in many autoimmune diseases. Susceptible animals and humans may have specific defects in their suppressor cell repertoire which allow inadvertent responses to self-antigens (65) . Several groups report defective suppressor cell activity in myocarditis patients not found in healthy individuals or persons with other forms of heart disease (26, 90) . Also, suppressor cells may play a role in determining susceptibility or resistance to CVB3-induced murine myocarditis. Under certain conditions, virus infection of the myocardium fails to elicit an inflammatory response.
Although most forms of autoimmune disease are predominant in females, in the murine myocarditis model male mice are highly susceptible while females are largely resistant (58) . This resistance can be eliminated, however, during pregnancy and in the postpartum period when female animals develop as much or more severe myocarditis than males (84) . Interestingly, this pattern is also present in humans. As of 1980, approximately two-thirds of myocarditis cases were reported in men. Of the remaining cases occurring in women, the majority arose during the third trimester of pregnancy and in the postpartum period (147) . Thus, epidemiologically, the murine disease resembles the human disease with surprising accuracy. Animal studies indicate that female resistance is complex, but depends primarily on the protective effects of estrogens, while susceptibility in males and pregnant females results from elevated androgen (testosterone and progesterone) levels. The latter hormones enhance picornavirus receptor expression on cardiocytes nearly fourfold. Virus localizes and replicates more rapidly in the hearts of androgen-treated animals (85) and stimulates autoimmune cellular and humoral responses which are noticeably absent in estrogen-treated mice (83, 84) . Lack of autoimmune reactivity in the latter case depends exclusively on the preferential induction of antigen-specific suppressor cells (65) . Why estrogens promote suppressor cell generation while androgens support autoimmunity is not known. However, current evidence implicates the virus receptor as an important element in autoimmune responses (25, 70, 93) . Androgen-treated cardiocytes show concurrent augmentation in both receptor expression and antigenicity for autoimmune CTL, proving the initial suggestion that these autoimmune mediators may recognize the receptor as their target antigen (85) . Subsequent work with monoclonal antibodies to the CVB3 receptor on murine heart cells confirms this supposition (57a (9, 142) . A second similar mechanism requires either haptenization of the self-molecule with a highly antigenic moiety or inoculation of the functional molecule from a different species which bears marked similarities to the self-antigen, yet also possesses important antigenic "foreignness." For example, hemolytic anemia has been reported after injection of mice with haptenized syngeneic erythrocytes (102) . While destruction of the haptenated cells would be expected, because of the added antigenic moiety, normal erythrocytes were also destroyed. Weigle initiated autoimmune thyroiditis in mice by inoculating these animals with bovine thyroglobulin (142) . Finally, and perhaps of most relevance, several studies have demonstrated induction of autoimmune-like diseases after virus infection and specifically when animals are given virus covalently adsorbed to cell membranes, presumably attached to the specific virus receptor (25) . Under these conditions, the virus presumably acts as a "hapten" for the self-molecule. How alterations in self-molecules result in autoimmunization is only partially understood. Although tolerance exists at the level of both T and B lymphocytes, persistent nonreactivity usually depends on deletion or inactivation of self-recognizing T-cell clones. Thus, autoreactive B cells may be present commonly, yet fail to give rise to detectable autoimmunity in the absence of appropriate Thelper cells. However, when an autoantigen is modified with an "antigenic" component for which appropriate T-helper cells exist, these T cells may inadvertently supply the required lymphokines and cellular interactions necessary to stimulate the autoimmune B cells (142) . Similarly, some self-molecules may be antigenic to both T-and B-cell clones, but are never appropriately presented to the immune system in conjunction with the proper MHC antigens to stimulate autoimmune responses. The function of the adjuvant or antigenic hapten or both may be primarily to either (i) facilitate antigen presentation of the self-molecules by concentrating inflammatory cells in the vicinity of the selfmolecules, thus enhancing phagocytosis of both stimulating and self-antigens; or (ii) elicit gamma interferon release from T cells stimulated to the antigenic moiety which will induce MHC expression on tissues. In the latter case, the inappropriate expression of the MHC antigens may cause the tissues themselves to take on many of the required characteristics of antigen-presenting cells and stimulate autoimmunity.
Finally, autoimmunity may result as a consequence of anti-idiotypic immunity (13, 112) . Because of the large array of potential antigenic epitopes each individual can recognize, very few T and B cells committed to a particular epitope exist within the body under normal circumstances. When antigenic stimulation occurs, a rapid clonal expansion of the involved cells takes place and antibodies are produced with specific variable regions or idiotypes for binding to the inducing antigen. The change from a paucity to an abundance of the particular idiotype frequently results in induc-CLIN. MICROBIOL Since much of the information outlined here depends heavily on animal models, one might question whether the experimental data truly reflect the human experience. This vital point cannot be addressed at this time because the data are incomplete. There definitely are areas of striking similarity between the human disease and murine myocarditis, both in the appearance of histologic lesions and in the demonstration of various cellular and humoral autoimmune responses, yet differences also exist. How important these differences prove to be and whether the animal models facilitate development of improved methods for diagnosis and treatment of the human disease may depend largely on the ability of the experimentalist and the clinician to work together in finding a solution to this problem.
